Please enable JavaScript to continue using this application.

Compare $CNXU vs $HUMA | Chartloom

Compare

$CNXU vs $HUMA

Conexeu Sciences Inc · Humacyte Inc

CNXU

Conexeu Sciences Inc

HUMA

Humacyte Inc

Compare $CNXU vs $HUMA

Comparing Conexeu Sciences Inc and Humacyte Inc

CNXUConexeu Sciences Inc

HUMAHumacyte Inc

CNXUConexeu Sciences Inc

Market cap

$104M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.2%

52W performance

-70.2%

FCF yield

-11.4%

HUMAHumacyte Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.62x

Rev growth (TTM)

159.3%

YTD performance

-58.4%

52W performance

-76.0%

FCF yield

-89.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CNXU

HUMA

Detailed metrics comparison

CNXU

Conexeu Sciences Inc

HUMA

Humacyte Inc

Market Cap

CNXU$104M

HUMA$109M

Enterprise Value

CNXU$102M

HUMA$96M

Price

CNXU$3.89

HUMA$0.41

P/E Ratio

CNXUN/A

HUMAN/A

P/S Ratio

CNXU0.00x

HUMA51.53x

EV/Sales

CNXU0.00x

HUMA45.06x

EV/EBITDA

CNXU0.00x

HUMA0.00x

P/B Ratio

CNXU14.95x

HUMA4.63x

P/FCF Ratio

CNXUN/A

HUMAN/A

EV/FCF

CNXU-8.61x

HUMA-0.98x

PEG Ratio

CNXUN/A

HUMAN/A

Forward P/E (NTM)

CNXUN/A

HUMAN/A

Forward P/S (NTM)

CNXUN/A

HUMA14.62x

Revenue (TTM)

CNXU$0

HUMA$2M

Revenue Growth (YoY)

CNXUN/A

HUMA159.3%

Forward Rev Growth

CNXU88.8%

HUMA520.3%

Gross Margin (TTM)

CNXU0.0%

HUMA-494.6%

Operating Margin (TTM)

CNXU0.0%

HUMA0.0%

EBITDA Margin (TTM)

CNXU0.0%

HUMA-4900.0%

Net Margin (TTM)

CNXU0.0%

HUMA-4560.8%

FCF Margin (TTM)

CNXUN/A

HUMA-4599.7%

Net Income (TTM)

CNXU$-16M

HUMA$-97M

FCF (TTM)

CNXU$-12M

HUMA$-98M

EPS (TTM)

CNXU-$0.58

HUMA-$0.41

ROE (TTM)

CNXU-23026.0%

HUMA-51675.0%

ROA (TTM)

CNXU-20389.0%

HUMA-8476.0%

ROIC (TTM)

CNXU-23026.0%

HUMA-9784.0%

Cash

CNXU$2M

HUMA$80M

Debt

CNXU$0

HUMA$66M

Net Cash/Debt

CNXU$2M

HUMA$14M

Current Ratio (TTM)

CNXU5.31x

HUMA6.21x

Quick Ratio (TTM)

CNXU1.74x

HUMA5.38x

Debt/Equity (TTM)

CNXU0.00x

HUMA2.12x

Debt/Assets (TTM)

CNXU0.0%

HUMA0.0%

Interest Coverage (TTM)

CNXUN/A

HUMAN/A

Net Debt/EBITDA (TTM)

CNXU0.00x

HUMA0.00x

Beta

CNXU-2.20

HUMA2.76

52W Performance

CNXU-70.2%

HUMA-76.0%

YTD Performance

CNXU-70.2%

HUMA-58.4%

% from 52W High

CNXU-79.3%

HUMA-78.6%

% from 52W Low

CNXU27.5%

HUMA3.7%

Asset Turnover (TTM)

CNXU0.00x

HUMA0.02x

FCF Yield (TTM)

CNXU-11.4%

HUMA-89.3%

Earnings Yield (TTM)

CNXU-15.1%

HUMA-88.5%

Dividend Yield (TTM)

CNXUN/A

HUMAN/A

Rule of 40

CNXU0.0

HUMA-4,440.4

EV/GP/RG

CNXUN/A

HUMAN/A

Ticker research

View CNXU research View HUMA research

Metric	CNXU Conexeu Sciences Inc	HUMA Humacyte Inc
Market & Valuation
Market Cap	$104M	$109M
Enterprise Value	$102M	$96M
Price	$3.89	$0.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	51.53x
EV/Sales	0.00x	45.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.95x	4.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.61x	-0.98x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	14.62x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	159.3%
Forward Rev Growth	88.8%	520.3%
Profitability
Gross Margin (TTM)	0.0%	-494.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-4900.0%
Net Margin (TTM)	0.0%	-4560.8%
FCF Margin (TTM)	N/A	-4599.7%
Net Income (TTM)	$-16M	$-97M
FCF (TTM)	$-12M	$-98M
EPS (TTM)	-$0.58	-$0.41
ROE (TTM)	-23026.0%	-51675.0%
ROA (TTM)	-20389.0%	-8476.0%
ROIC (TTM)	-23026.0%	-9784.0%
Financial Health
Cash	$2M	$80M
Debt	$0	$66M
Net Cash/Debt	$2M	$14M
Current Ratio (TTM)	5.31x	6.21x
Quick Ratio (TTM)	1.74x	5.38x
Debt/Equity (TTM)	0.00x	2.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.20	2.76
52W Performance	-70.2%	-76.0%
YTD Performance	-70.2%	-58.4%
% from 52W High	-79.3%	-78.6%
% from 52W Low	27.5%	3.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-11.4%	-89.3%
Earnings Yield (TTM)	-15.1%	-88.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,440.4
EV/GP/RG	N/A	N/A
Ticker research	View CNXU research	View HUMA research

Valuation

P/S Ratio

CNXU

0.00x

HUMA

51.53x

EV/FCF

CNXU

-8.61x

HUMA

-0.98x

Growth & revenue

Revenue Growth TTM

HUMA

159.3%

Forward Revenue Growth

HUMA

520.3%

CNXU

88.8%

Profitability & performance

Gross Margin

CNXU

0.0%

HUMA

-494.6%

ROE

CNXU

-23026.0%

HUMA

-51675.0%

FCF Yield %

CNXU

-11.4%

HUMA

-89.3%

52-Week Performance

CNXU

-70.2%

HUMA

-76.0%

Detailed metrics comparison

CNXU

Conexeu Sciences Inc

HUMA

Humacyte Inc

Market Cap

CNXU$104M

HUMA$109M

Enterprise Value

CNXU$102M

HUMA$96M

Price

CNXU$3.89

HUMA$0.41

P/E Ratio

CNXUN/A

HUMAN/A

P/S Ratio

CNXU0.00x

HUMA51.53x

EV/Sales

CNXU0.00x

HUMA45.06x

EV/EBITDA

CNXU0.00x

HUMA0.00x

P/B Ratio

CNXU14.95x

HUMA4.63x

P/FCF Ratio

CNXUN/A

HUMAN/A

EV/FCF

CNXU-8.61x

HUMA-0.98x

PEG Ratio

CNXUN/A

HUMAN/A

Forward P/E (NTM)

CNXUN/A

HUMAN/A

Forward P/S (NTM)

CNXUN/A

HUMA14.62x

Revenue (TTM)

CNXU$0

HUMA$2M

Revenue Growth (YoY)

CNXUN/A

HUMA159.3%

Forward Rev Growth

CNXU88.8%

HUMA520.3%

Gross Margin (TTM)

CNXU0.0%

HUMA-494.6%

Operating Margin (TTM)

CNXU0.0%

HUMA0.0%

EBITDA Margin (TTM)

CNXU0.0%

HUMA-4900.0%

Net Margin (TTM)

CNXU0.0%

HUMA-4560.8%

FCF Margin (TTM)

CNXUN/A

HUMA-4599.7%

Net Income (TTM)

CNXU$-16M

HUMA$-97M

FCF (TTM)

CNXU$-12M

HUMA$-98M

EPS (TTM)

CNXU-$0.58

HUMA-$0.41

ROE (TTM)

CNXU-23026.0%

HUMA-51675.0%

ROA (TTM)

CNXU-20389.0%

HUMA-8476.0%

ROIC (TTM)

CNXU-23026.0%

HUMA-9784.0%

Cash

CNXU$2M

HUMA$80M

Debt

CNXU$0

HUMA$66M

Net Cash/Debt

CNXU$2M

HUMA$14M

Current Ratio (TTM)

CNXU5.31x

HUMA6.21x

Quick Ratio (TTM)

CNXU1.74x

HUMA5.38x

Debt/Equity (TTM)

CNXU0.00x

HUMA2.12x

Debt/Assets (TTM)

CNXU0.0%

HUMA0.0%

Interest Coverage (TTM)

CNXUN/A

HUMAN/A

Net Debt/EBITDA (TTM)

CNXU0.00x

HUMA0.00x

Beta

CNXU-2.20

HUMA2.76

52W Performance

CNXU-70.2%

HUMA-76.0%

YTD Performance

CNXU-70.2%

HUMA-58.4%

% from 52W High

CNXU-79.3%

HUMA-78.6%

% from 52W Low

CNXU27.5%

HUMA3.7%

Asset Turnover (TTM)

CNXU0.00x

HUMA0.02x

FCF Yield (TTM)

CNXU-11.4%

HUMA-89.3%

Earnings Yield (TTM)

CNXU-15.1%

HUMA-88.5%

Dividend Yield (TTM)

CNXUN/A

HUMAN/A

Rule of 40

CNXU0.0

HUMA-4,440.4

EV/GP/RG

CNXUN/A

HUMAN/A

Ticker research

View CNXU research View HUMA research

Metric	CNXU Conexeu Sciences Inc	HUMA Humacyte Inc
Market & Valuation
Market Cap	$104M	$109M
Enterprise Value	$102M	$96M
Price	$3.89	$0.41
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	51.53x
EV/Sales	0.00x	45.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	14.95x	4.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.61x	-0.98x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	14.62x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	159.3%
Forward Rev Growth	88.8%	520.3%
Profitability
Gross Margin (TTM)	0.0%	-494.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-4900.0%
Net Margin (TTM)	0.0%	-4560.8%
FCF Margin (TTM)	N/A	-4599.7%
Net Income (TTM)	$-16M	$-97M
FCF (TTM)	$-12M	$-98M
EPS (TTM)	-$0.58	-$0.41
ROE (TTM)	-23026.0%	-51675.0%
ROA (TTM)	-20389.0%	-8476.0%
ROIC (TTM)	-23026.0%	-9784.0%
Financial Health
Cash	$2M	$80M
Debt	$0	$66M
Net Cash/Debt	$2M	$14M
Current Ratio (TTM)	5.31x	6.21x
Quick Ratio (TTM)	1.74x	5.38x
Debt/Equity (TTM)	0.00x	2.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-2.20	2.76
52W Performance	-70.2%	-76.0%
YTD Performance	-70.2%	-58.4%
% from 52W High	-79.3%	-78.6%
% from 52W Low	27.5%	3.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-11.4%	-89.3%
Earnings Yield (TTM)	-15.1%	-88.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-4,440.4
EV/GP/RG	N/A	N/A
Ticker research	View CNXU research	View HUMA research